FI91073B - Ett förbättrade förfarande och peptid för detektering av AIDS-besläktade sjukdomar - Google Patents
Ett förbättrade förfarande och peptid för detektering av AIDS-besläktade sjukdomarInfo
- Publication number
- FI91073B FI91073B FI865313A FI865313A FI91073B FI 91073 B FI91073 B FI 91073B FI 865313 A FI865313 A FI 865313A FI 865313 A FI865313 A FI 865313A FI 91073 B FI91073 B FI 91073B
- Authority
- FI
- Finland
- Prior art keywords
- aids
- peptide
- detection
- improved method
- related diseases
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 208000012124 AIDS-related disease Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 239000010836 blood and blood product Substances 0.000 abstract 1
- 229940125691 blood product Drugs 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72805285A | 1985-04-29 | 1985-04-29 | |
US72805285 | 1985-04-29 | ||
US76730385 | 1985-08-19 | ||
US06/767,303 US4629783A (en) | 1985-04-29 | 1985-08-19 | Synthetic antigen for the detection of AIDS-related disease |
US84448586A | 1986-03-26 | 1986-03-26 | |
US84448586 | 1986-03-26 | ||
US8600831 | 1986-04-21 | ||
PCT/US1986/000831 WO1986006414A1 (en) | 1985-04-29 | 1986-04-21 | Synthetic antigens for the detection of aids-related disease |
Publications (4)
Publication Number | Publication Date |
---|---|
FI865313A FI865313A (sv) | 1986-12-29 |
FI865313A0 FI865313A0 (sv) | 1986-12-29 |
FI91073B true FI91073B (sv) | 1994-01-31 |
FI91073C FI91073C (sv) | 1994-05-10 |
Family
ID=27419109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI865313A FI91073C (sv) | 1985-04-29 | 1986-12-29 | Ett förbättrade förfarande och peptid för detektering av AIDS-besläktade sjukdomar |
Country Status (8)
Country | Link |
---|---|
US (2) | US6485900B1 (sv) |
EP (1) | EP0220273B2 (sv) |
KR (1) | KR910002374B1 (sv) |
AT (1) | ATE116006T1 (sv) |
DE (1) | DE3650175T3 (sv) |
DK (2) | DK171250B1 (sv) |
FI (1) | FI91073C (sv) |
WO (1) | WO1986006414A1 (sv) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341482C (en) | 1984-10-31 | 2005-05-10 | Paul A. Luciw | Process for preparing fragments of aids-associated retroviruses |
US7273695B1 (en) | 1984-10-31 | 2007-09-25 | Novartis Vaccines And Diagnostics, Inc. | HIV immunoassays using synthetic envelope polypeptides |
US7285271B1 (en) | 1984-10-31 | 2007-10-23 | Novartis Vaccines And Diagnostics, Inc. | Antigenic composition comprising an HIV gag or env polypeptide |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
JP2702911B2 (ja) * | 1985-09-11 | 1998-01-26 | ユナイテツド・バイオメデイカル・インコ−ポレ−テツド | 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法 |
GB8525615D0 (en) * | 1985-10-17 | 1985-11-20 | Hoffmann La Roche | Polypeptides |
US7115363B1 (en) | 1986-01-22 | 2006-10-03 | Institut Pasteur | Retrovirus capable of causing AIDS, means and methods for detecting it in vitro |
US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
FR2625100A2 (fr) * | 1986-03-13 | 1989-06-30 | Lurhuma Zirimwabagabo | Utilisation d'antigenes pour la preparation de vaccins, proteine rendue immunogene et composition pharmaceutique la comportant |
US5075211A (en) * | 1986-03-26 | 1991-12-24 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4879212A (en) * | 1986-04-02 | 1989-11-07 | United Biomedical Inc. | Peptide composition and method for the detection of antibodies to HTLV-III |
US4925784A (en) * | 1986-04-04 | 1990-05-15 | Hoffmann-La Roche Inc. | Expression and purification of an HTLV-III gag/env gene protein |
DK169582B1 (da) * | 1986-06-23 | 1994-12-12 | Squibb Bristol Myers Co | Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant |
US5087557A (en) * | 1986-06-23 | 1992-02-11 | Genetic Systems Corporation | Human monoclonal antibody to lymphadenopathy-associated virus |
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
WO1988005783A1 (en) * | 1987-01-28 | 1988-08-11 | Ortho Pharmaceutical Corporation | Immunosuppressive peptides and methods of use |
DE3850593T3 (de) * | 1987-03-25 | 2001-01-04 | Genetic Systems Corp., Seattle | Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten. |
NO881151L (no) * | 1987-03-27 | 1988-09-28 | Syntello Ab | Syntetisk hiv-1-antigen. |
SE8701628D0 (sv) * | 1987-04-16 | 1987-04-16 | Erling Norrby | Medel for analys mm |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
US4921787A (en) * | 1987-05-01 | 1990-05-01 | Cambridge Bioscience Corporation | Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex |
FI872409A0 (fi) * | 1987-05-29 | 1987-05-29 | Labsystems Oy | Foerfarande foer detektering av hiv-1 motkroppar. |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
NZ226026A (en) * | 1987-09-04 | 1991-03-26 | Wellcome Found | Immunoassay for an antibody using recombinant antigens expressed in two different genera |
SE8704185L (sv) * | 1987-10-28 | 1989-04-29 | Ferring Ab | Nya peptider, artificiella antigener och immunoanalystestsatser |
US7442525B1 (en) | 1987-12-24 | 2008-10-28 | Novartis Vaccines And Diagnostics, Inc. | Method for expressing HIV polypeptides |
SE8705197D0 (sv) * | 1987-12-30 | 1987-12-30 | Jonas Blomberg | New peptides, two diagnostic methods using the peptides and a medicament based on the peptides |
US6218102B1 (en) * | 1988-01-27 | 2001-04-17 | Biochem Immunosystems, Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
US6210874B1 (en) | 1988-01-27 | 2001-04-03 | Biochem Immunosystems, Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
US5241047A (en) * | 1988-12-08 | 1993-08-31 | Biochem Pharma Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
US6214537B1 (en) | 1988-01-27 | 2001-04-10 | Biochem Immunosystems, Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
ATE134195T1 (de) * | 1988-06-10 | 1996-02-15 | United Biomedical Inc | Peptidfragmente von hiv |
GB8828097D0 (en) * | 1988-12-01 | 1989-01-05 | Wellcome Found | Peptides |
GB8828098D0 (en) * | 1988-12-01 | 1989-01-05 | Wellcome Found | Peptides |
GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
WO1991008227A1 (en) * | 1989-11-27 | 1991-06-13 | Replico Medical Aktiebolag | NEW HIV-1 p17 PEPTIDES, DIAGNOSTIC ANTIGENS AND IMMUNOASSAY METHOD |
US6248574B1 (en) * | 1989-12-13 | 2001-06-19 | Avigdor Shaffermann | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
EP0510054A1 (en) * | 1990-01-05 | 1992-10-28 | United Biomedical, Inc. | Hiv-1 core protein fragments |
FR2657017B1 (fr) * | 1990-01-16 | 1995-08-18 | Clonatec Sa | Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. |
EP0438332B1 (fr) * | 1990-01-16 | 1998-04-08 | Orgenics Ltd. | Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA |
SE468168B (sv) * | 1990-02-20 | 1992-11-16 | Replico Medical Ab | Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov |
SE470074B (sv) * | 1990-08-16 | 1993-11-01 | Replico Medical Ab | Förfarande för diagnos av picorna- och/eller flavivirusinfektion, peptider, diagnostiska antigener och vaccinkomposition med dessa peptider |
DE4039925A1 (de) * | 1990-12-14 | 1992-06-17 | Behringwerke Ag | Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung |
AU4387193A (en) * | 1992-05-29 | 1993-12-30 | Abbott Laboratories | Ligase chain reaction starting with rna sequences |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
FR2732346B1 (fr) * | 1995-03-27 | 1997-05-30 | Centre Nat Rech Scient | Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications |
FR2773156B1 (fr) * | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
FR2781158B1 (fr) | 1998-07-15 | 2002-12-13 | Vacs Internat | Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications |
CA2676762C (en) * | 1998-11-30 | 2015-12-29 | Ortho-Clinical Diagnostics, Inc. | Peptides for the detection of hiv-1 group o |
FR2802426B1 (fr) | 1999-12-15 | 2004-04-02 | Neovacs | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires |
DE60336978D1 (de) * | 2003-04-11 | 2011-06-16 | Pasteur Institut | Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper |
FR2882557A1 (fr) * | 2005-02-25 | 2006-09-01 | Centre Nat Rech Scient | Epitopes de vih et composition pharmaceutique les contenant |
AU2016218254B2 (en) | 2015-02-09 | 2019-12-19 | Slingshot Biosciences, Inc. | Hydrogel particles with tunable optical properties and methods for using the same |
US11313782B2 (en) | 2020-01-24 | 2022-04-26 | Slingshot Biosciences, Inc. | Compositions and methods for cell-like calibration particles |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
FR2571968B1 (fr) | 1984-10-18 | 1989-03-17 | Pasteur Institut | Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections. |
GB8429099D0 (en) | 1984-11-16 | 1984-12-27 | Pasteur Institut | Closed dna sequences |
US4520113A (en) * | 1984-04-23 | 1985-05-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions |
GB8501473D0 (en) | 1985-01-21 | 1985-02-20 | Pasteur Institut | Cloned dna sequences |
ES8705522A1 (es) | 1984-10-18 | 1987-05-01 | Pasteur Institut | Un procedimiento para la preparacion de derivados purificados de una glicoproteina. |
US4774175A (en) | 1985-03-01 | 1988-09-27 | Centocor, Inc. | Immunochemical methods for the detection of antibody against HTLV-III |
US4784941A (en) | 1985-04-08 | 1988-11-15 | Genetic Systems Corporation | Expression and diagnostic use of pENV-3 encoded peptides which are immunologically reactive with antibodies to LAV |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
US4843011A (en) | 1985-08-01 | 1989-06-27 | Akzo N.V. | Monoclonal antibodies for binding HTLV-III proteins, and cell lines for their production |
US4735896A (en) * | 1986-03-04 | 1988-04-05 | United Biomedical, Inc. | Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions |
US4803156A (en) * | 1985-09-11 | 1989-02-07 | New York Blood Center | Peptide-beta-lactamase conjugates for enzyme-linked immunoassays |
US4956273A (en) | 1985-10-24 | 1990-09-11 | Southwest Foundation For Biomedical Research | Synthetic peptides and method of use for diagnosis and vaccination for AIDS and ARC |
US4839288A (en) | 1986-01-22 | 1989-06-13 | Institut Pasteur | Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
US4772547A (en) * | 1986-02-03 | 1988-09-20 | Hoffmann-La Roche Inc. | HTLV-III envelope peptides |
US4753873A (en) | 1986-02-03 | 1988-06-28 | Cambridge Bioscience Corporation | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use |
US4808536A (en) | 1986-02-27 | 1989-02-28 | Centocor, Inc. | Immunochemical method for detection of antibody against HTLV-III core protein based upon recombinant HTLV-III gag gene encoded protein |
US4879212A (en) | 1986-04-02 | 1989-11-07 | United Biomedical Inc. | Peptide composition and method for the detection of antibodies to HTLV-III |
US4957737A (en) | 1986-05-27 | 1990-09-18 | Hoffmann-La Roche Inc. | HTLV-III (LAV) envelope peptides |
US5017688A (en) | 1986-06-12 | 1991-05-21 | Biogen, Inc. | Peptides involved in the pathogenesis of HIV infection |
US4861707A (en) | 1987-02-02 | 1989-08-29 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus antigen |
US4943628A (en) | 1988-06-13 | 1990-07-24 | Ortho Pharmaceutical Corporation | HIV peptide-inducted T cell stimulation |
-
1986
- 1986-04-21 DE DE3650175T patent/DE3650175T3/de not_active Expired - Lifetime
- 1986-04-21 KR KR1019860700948A patent/KR910002374B1/ko not_active IP Right Cessation
- 1986-04-21 WO PCT/US1986/000831 patent/WO1986006414A1/en active IP Right Grant
- 1986-04-21 EP EP86902998A patent/EP0220273B2/en not_active Expired - Lifetime
- 1986-04-21 AT AT86902998T patent/ATE116006T1/de not_active IP Right Cessation
- 1986-12-23 DK DK626486A patent/DK171250B1/da not_active IP Right Cessation
- 1986-12-29 FI FI865313A patent/FI91073C/sv not_active IP Right Cessation
-
1990
- 1990-06-20 US US07/541,163 patent/US6485900B1/en not_active Expired - Lifetime
-
1994
- 1994-06-01 US US08/252,987 patent/US6214539B1/en not_active Expired - Lifetime
-
1995
- 1995-07-18 DK DK084195A patent/DK84195A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE116006T1 (de) | 1995-01-15 |
FI865313A (sv) | 1986-12-29 |
AU597884B2 (en) | 1990-06-14 |
EP0220273B2 (en) | 2007-01-17 |
DE3650175D1 (de) | 1995-02-02 |
EP0220273B1 (en) | 1994-12-21 |
DK84195A (da) | 1995-07-18 |
DK171250B1 (da) | 1996-08-12 |
US6214539B1 (en) | 2001-04-10 |
AU5773386A (en) | 1986-11-18 |
WO1986006414A1 (en) | 1986-11-06 |
KR910002374B1 (ko) | 1991-04-20 |
DK626486D0 (da) | 1986-12-23 |
US6485900B1 (en) | 2002-11-26 |
EP0220273A4 (en) | 1989-10-04 |
EP0220273A1 (en) | 1987-05-06 |
FI91073C (sv) | 1994-05-10 |
DK626486A (da) | 1986-12-23 |
KR880700080A (ko) | 1988-02-15 |
DE3650175T3 (de) | 2007-09-06 |
DE3650175T2 (de) | 1995-06-14 |
FI865313A0 (sv) | 1986-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI91073B (sv) | Ett förbättrade förfarande och peptid för detektering av AIDS-besläktade sjukdomar | |
ES8708058A1 (es) | Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii | |
DE3752170D1 (de) | Synthetisches Antigen zum Nachweis von mit AIDS in Zusammenhang stehenden Krankheiten | |
FI861626A (fi) | Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids. | |
DK614987D0 (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
FI101453B (sv) | Förfarande och DNA-sekvenser för framställning av rekombinant-coccidio sisvaccin | |
NO831317L (no) | Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner. | |
NO174105C (no) | Analogifremgangsmåte for fremstilling av antikoagulerende peptider | |
ES2101388T3 (es) | Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c. | |
FI854383A (fi) | Foerfarande foer avspaltning av peptider och proteiner av metionyl-bindning. | |
NO861355L (no) | Ekspresjon av immunologisk reaktive virusproteiner. | |
HUT44622A (en) | New antigen-active proteins and peptides and feline peritonitis virus vaccine (fipv) | |
NO964874L (no) | Fusjonsglykoprotein fra HCMV og HSV | |
DK2086D0 (da) | Protraheret virkende sterilt vandigt praeparat af et peptid eller protein, dets fremstilling og anvendelse | |
DE69841664D1 (de) | Synthetisches Antigen zum Nachweis von HIV-immunreaktiven Antikörpern | |
DK257887D0 (da) | Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden | |
TW369600B (en) | Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same | |
IT8349430A0 (it) | Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: GENETIC SYSTEMS CORPORATION |
|
MA | Patent expired |